MedTrace Logo

Clinical Evaluation of the CARTO™ XP EP Navigation System v9 and Biosense Webster SOUNDSTAR 3D Diagnostic Ultrasound. A Feasibility Study

NCT00449085 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2025-02-03

No results posted yet for this study

Summary

Feasibility study to evaluate CARTO™ XP EP Navigation System V9 and SOUNDSTAR 3D Diagnostic Ultrasound Catheter.

Conditions

Interventions

PROCEDURE

Electrophysiology

DEVICE

CARTO™ XP EP Navigation System V9

Sponsors & Collaborators

  • Royal Adelaide Hospital

    collaborator OTHER

  • Melbourne Health

    collaborator OTHER

  • Biosense Webster, Inc.

    lead INDUSTRY

Principal Investigators

  • Prashanthan Sanders, MBBS,PhD,FRCACP · Royal Adelaide Hospital

  • Jonathan Kalman, MBBS,PhD,FRACP · Melbourne Health

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2012-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00449085 on ClinicalTrials.gov